
    
      Progesterone improves secondary outcomes such as gestation at delivery, on-going pregnancy at
      12 weeks, survival at 28 days of neonatal life.

      . Progesterone, compared to placebo, does not incur substantial adverse effects to the mother
      or the neonate.

      Explore differential or subgroup effects of progesterone in prognostic subgroups.

      . Perform an economic evaluation for cost-effectiveness.
    
  